-
Clinical trial findings for new survodutide and semaglutide treatments and promising phase 2 retatrutide results.
-
Updates include teplizumab to delay type 1 diabetes onset and early screening for liver disease.
-
Heart failure and chronic kidney disease are the first and most frequent manifestations of cardiovascular disease in people with type 2 diabetes and are also associated with increased morbidity...
People with diabetes are more likely to have oral health complications compared to those without diabetes.
> Read more
People who smoke are at risk of developing type 2 diabetes, while for people living with diabetes, smoking can increase the risk of complications.
> Read more
Diabetes impacts more than 530 million people across the globe and is a major risk factor for cardiovascular disease — the leading cause of death in people with diabetes.
> Read more
IDF research underscores the urgent need for enhanced awareness and education about diabetes and its potential consequences.
> Read more
Diabetes-related eye conditions are common and can lead to vision loss, affecting a person's career, causing financial difficulties and interfering with daily diabetes management.
> Read more